Skip to main content



Local Cdiff information for Oklahoma

Oklahoma

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Oklahoma.



Local Cdiff information for Oklahoma

Oklahoma

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Oklahoma.

Providers

Regulation

C. diff Infections

Total Reported Cases: 833
Hospital Onset: 833
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.63
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Vonnie Meritt, RN, MPH, BSN
Director of Quality Initiatives
Oklahoma State Department of Health
1000 NE 10th
Oklahoma City, 73117
(405) 271-6576
(405) 271-1308
EMAIL VONNIE MERITT, RN, MPH, BSN >

CLINICAL TRIALS

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.